Modulation of Molecular Fingerprinting in Pediatric Sepsis
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Phoenix Children's Hospital
- Study ID
- NCT02055105
- Status
- Recruiting
Conditions
- Systemic Inflammatory Response Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- miRNA in Sepsis — PROCEDUREmiRNA in Sepsis
Study Details
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Key Dates
- Start date
- Mar 31, 2014
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: 10 Patients with sepsis or septic shockPreviously healthy, non-immunocompromised patients, between the ages of 1 and 18, who are being admitted to the PCH PICU for sepsis or septic shock, will be enrolled. Blood samples, urine samples and buccal swabs will be obtained from these patients at 5 time points to analyze biomarkers. Study participants will receive standard of care with antimicrobials and any additional appropriate cardiovascular or respiratory support per the clinical team. The samples will collected and stored at -80 until analysis can be performed. In addition to, during the course of the hospitalization, the enrolled patient will have data collected to calculate severity scores, including PRISM scores and TISS-28 scores. All patient information will be de-identified. A standard procedure manual will be developed detailing the methods for data collection and entry.
- Arm: 50 Healthy PatientsHealthy non-immunocompromised patients between 1-18 years old
Primary Outcome Measure
Risk of Mortality [ Time Frame: Duration of hospital stay, an expected average of 3 weeks ]
Central Contacts
- Frederick A Willyerd, MD6029331784
- Althaia Calla G Ignacio, BSN, MD6029333795
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | |
| Phoenix Children's Hospital | Phoenix | Arizona | 85019 |
Find similar trials in Phoenix, AZ
By research site
Related Studies
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?Recruiting · Michigan State University · Lansing, Michigan
- Conventional Ultrafiltration Versus Dilutional Ultrafiltration in Pediatric CPB PatientsNot Yet Recruiting · Akron Children's Hospital · Akron, Ohio